OUR VISION
Supply chain oversight partner.
To be the supply chain oversight partner of choice for International Pharma /Biopharma companies for product release into Europe.
MIAS INSIGHT
Latest Market & MIAS Updates.
Trials or Post-Brexit Imperative: A Guide to Successful UK-EU Clinical Trials Compliance
Achieving success in a UK-EU clinical trial requires the implementation of effective strategies for the release of Investigational Medicinal Products (IMPs), demanding
How would an Auditor qualify a warehouse provider to ensure they are in compliance with Annex 21?
Annex 21 of the Good Manufacturing Practice (GMP) guidelines for medicinal products outlines the requirements for the importation of medicinal products into
How would a Physical Site of Importation (SOI) handle customs clearance?
A Physical Site of Importation (SOI) in the pharmaceutical industry plays a crucial role in handling customs clearance for pharmaceutical products. Customs